Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yesterday it also dropped early on only to finish in positive territory by close. Maybe the same will happen again today.
1.5mill for both the uk and Belgium (67mill and 11.7mill populations respectively) is quite good for just 2 months. Remember the response to the FDA approval RNS, the sp hardly moved. Whodunnit have guessed.
This is a money maker in the making. With a little time, it will start to gain traction. That said, one would have thought they would have had a US licensee waiting at the gates ready for the off which doesn’t appear to be the case.
Wouldn't argue with that bignose.just have to see how it goes.
Just remember it also dropped 4.5% yesterday too, so although it could be considered as fairly good news, there will always be sellers, particularly after the recent increases. I’m going to make a guess that it will possibly gain later in the day once the %traders have finished. But I have been known to be wrong….lol
Looking at the s/p reaction so far (down 4% as i type)i think the number has been perceived a little negatively.my own view is that there is almost always excessive optimism about figures for sales,based on total market size and maximum capture projections etc. bearing in mind it is (apparently?)only uk and belgium and its only a couple of months, i thought figure was perfectly satisfactory.i think fum must think that as well,as they were not obliged to give any figure at this point.i realise we have the presentations now,so may have felt some pressure to give out a figure,but if it was less than good they could easily have just said too early etc.im quite happy atm,but im no expert lol.
Not sure what to make of the FUM RNS. 1.5mill seems Low, however. I expect it’s all from boots sales in the UK, which started only a few months ago which could mean 1.5mill is good going. What do you think?
Morning The.Italian. I’m sure they won’t rock the boat since they will have to have ticked the box JM YES men…..lol
Morning bignose.wonder whether the change of auditor will result in any change of accounting approach.dont suppose the new lot would have been appointed if they were going to rock the boat, but we will see.
HKRX closed today and tomorrow due to the dragon boat festival.
Well, there was an announcement although the subject not what i was expecting.
Now what....
BDO has confirmed in its resignation letter to the Company and the audit committee of the
Company (the ‘‘Audit Committee’’) that there are no matters in respect of its resignation that
need to be brought to the attention of the shareholders of the Company (the ‘‘Shareholders’’).
Although no reason given, I expect they have thrown in the towel because they are fed up waiting for some real accounts they can get their teeth into. Rather than the usual jiggery pokery to try and make the accounts look decent. Certainly could indicate they are not expecting any injection of money anytime soon. Just speculation on my part, but usually accounting companies don't resign a few days before the mid year interim results coming up without some reason.
And ???
More in and out on acc .
WENDURANCE RP LTD - No out of acc and ENDURANCE RP LTD in .
Current price = 0.66
Down since last look .
Yes would agree with that.when i posted about uk inflation fum were 4%down,but now flat,so hoping for blue day by cop.
I think given the FDA approval. the trend is now upwards. Yes, profit taking in the morning, but up again in positive territory once the sellers have taken their 10%....lol
Up 4.5% on no volume, could this mean M&Ms have access to some news. Interesting to see if there is any announcement this evening.
Actually just looked at uk main markets and they are hardly down,so perhaps today's drop on fum is just profit taking after recent rise.still confident in long term potential now after FDA approval.
Morning bignose.yes good day on fum yesterday,today not so much im afraid.uk inflation figure out.unchanged which is a real shock.not really directly relevant to FUM,but no doubt creating a very negative market sentiment.will be interesting to see what response is to the investor and retail events in next few days.
Morning The.Italian,
Obviously that was about yesterday, although maybe today too ? :-)
Nice to see FUM having a good day. Volume up as is the sp. Long may it continue. A lot of catching up to do here. ;-)
Morning The.Italian.
I wouldn’t underestimate their lack of communication since we have witnessed many times them failing to update the market/shareholders. They follow absolutely no fiduciary requirements.
Morning bignose.at end of march they said working towards completing SPA by end of Q2. so hopefully news one way or the other by middle to end of july.can't see how they can avoid informing market of outcome,so tense time now imo.
Of course that's me being pessimistic re the FDA and License agreement which is based on them taking 9 years to get this far. 5 years of which have been spent towards phase III. There is noting to say they may get a lifeline within the next 6 months, but I choose not to count on it as we have been thoroughly let down many times before.
Note: Even though have ref'd they have been in discussions with a Japanese licensee the last couple of years, I am sure they too will be waiting on an FDA result.
Onwards and sideways.
Love it bignose. I will go with your assumption!!!!
Fair enough bignose.i suppose i was thinking in terms of further dilution through a formal placing or another rights issue.if it looks as though funds will be coming in at the end of the day(albeit a while away)jim might be prepared to go down the loan route for operating expenses,rather than a share issue,but we can only guess at what his attitude might be. i agree that he won't sub the p111,so if no spa and no licence then not looking good for usa,imo.
Morning The.Italian,
I’m afraid I am not suggesting China will negate the need for yet another cash call since no monies will be forthcoming until the approval next year.
Since there won’t be anything coming from the US or even the EU (30k cans every 4 months won’t cut it), I expect that Jim will have to sub the company since there isn’t any money after Dec. I don’t see him subbing the phase iii but only the operating costs for both ERP and the DLI. I have no idea if the FDA have time limits between the end of phase II and the commencement of phase iii.
"...the little information", Bothwell? No shortage of public domain information with respect to Recordati's opinion on value, and there's enough of the Phase II data published to determine that it was a complete train wreck.
In short, next to nothing to come from Europe (and to rub salt in, royalty drops to 3% or less in under five years, if product still on the market), US is dead, not that there was ever any real prospect of approval. As for China, there's sufficient recent and high resolution data from Menarini Asia Pacific to be able to rough out a prevalence based model which indicates just how low sales (if approved) might be.